Streetbeat News

Earnings

EL

Estee Lauder shares are trading lower after L'Oreal reported worse-than-expected Q2 results.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 5:02 pm

COTY

EL

LRLCY

Coty shares are trading lower in sympathy with Estee Lauder after L'Oreal reported worse-than-expected Q2 sales results.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 5:02 pm

CVS

Deep-pocketed investors have shown a bullish approach towards CVS Health (NYSE:CVS) with significant options activity detected. The options market indicates a price range of $32.5 to $70.0 for CVS Health over the next three months. The stock is currently trading at $63.07, up by 2.44%, with an earnings announcement expected in 8 days.

Portfolio Pulse from Benzinga Insights

July 30, 2024 | 5:01 pm

AVGO

Broadcom (NASDAQ:AVGO) has seen unusual options activity with a bullish stance from significant investors. Out of 89 trades, 52 were calls and 37 were puts, with a total trade value of $6,311,122 for calls and $3,398,909 for puts. Analysts maintain high target prices, and the stock is currently down by 3.08% at $145.6.

Portfolio Pulse from Benzinga Insights

July 30, 2024 | 5:01 pm

CRWD

DAL

MSFT

CrowdStrike's recent security mishap, which caused a global IT outage affecting Microsoft systems, is expected to impact the company's revenue and market share for the next year. Despite the setback, Needham maintains a Buy rating on CrowdStrike but lowers the price target. Delta Air Lines is seeking compensation for the disruption. CrowdStrike's stock has dropped significantly since the incident.

Portfolio Pulse from Michael Juliano

July 30, 2024 | 5:00 pm

SYM

Symbotic, Inc. (NASDAQ:SYM) stock is trading lower after reporting worse-than-expected Q3 earnings and issuing Q4 guidance below estimates. The company reported a loss of two cents per share, missing analyst estimates, but beat sales expectations with $491.86 million. Analysts have adjusted their price targets following the report.

Portfolio Pulse from Dylan Berman

July 30, 2024 | 4:59 pm

INCY

Incyte Corporation (NASDAQ: INCY) reported Q2 revenue of $1.04 billion, beating expectations, but posted a wider-than-expected EPS loss of $(1.82). Jakafi sales guidance was raised, and Opzelura showed strong growth. The company announced a strategic pipeline review and positive Phase 3 results for retifanlimab. William Blair maintains an Outperform rating with a $89 price target.

Portfolio Pulse from Vandana Singh

July 30, 2024 | 4:57 pm

FSLR

First Solar Inc (NASDAQ:FSLR) shares are flat as investors await the company's second-quarter earnings report. Analysts expect EPS of $2.69 and revenue of $941.538 million. The stock has recently fallen due to increased tariffs on Chinese solar panels and market oversupply concerns.

Portfolio Pulse from Henry Khederian

July 30, 2024 | 4:50 pm

CGC

TLRY

Canopy Growth Corporation (NASDAQ:CGC) shares are trading higher due to positive earnings from Tilray Brands, Inc. (NASDAQ:TLRY) and favorable political developments for marijuana reform in the U.S. Canopy Growth is set to report its Q1 results on Aug. 9, with analysts expecting losses of 35 cents per share and revenue of $53.84 million.

Portfolio Pulse from Erica Kollmann

July 30, 2024 | 4:40 pm

IT

Gartner Inc (NYSE:IT) shares surged after reporting better-than-expected Q2 FY24 results, including a 6.1% sales growth, increased operating income, and higher adjusted EPS. The company also raised its share repurchase authorization and FY24 adjusted EPS outlook.

Portfolio Pulse from Shivani Kumaresan

July 30, 2024 | 4:40 pm